Get Your Personalized Supplement StackSupplement Stack Quiz

Ginkgo biloba Leaf Extract

Q: Is Ginkgo biloba safe for long-term use?

Yes, Ginkgo biloba is generally considered safe for long-term use, with mild side effects and no major safety concerns reported in long-term randomized controlled trials.

Q: Does Ginkgo biloba increase bleeding risk?

Evidence from a meta-analysis of 18 randomized controlled trials does not support an increased bleeding risk with typical doses of standardized Ginkgo biloba extract.

Q: When can cognitive benefits be expected from Ginkgo biloba?

Cognitive benefits from Ginkgo biloba are typically observed after approximately 3 months of continuous and consistent use.

Q: Can Ginkgo biloba be combined with Alzheimer’s medications?

Yes, studies have shown that combining Ginkgo biloba with medications like donepezil can lead to superior cognitive improvement in dementia patients.

Also known as: Maidenhair tree, Ginkgo, Ginkgo biloba leaf extract, GBE, Ginkgo biloba

Overview

Ginkgo biloba leaf extract (GBE) is derived from the leaves of the ancient Ginkgo biloba tree. It is widely recognized for its potential in cognitive enhancement, particularly in cases of mild cognitive impairment (MCI) and Alzheimer's disease (AD). Beyond cognitive benefits, GBE is also explored for its role in peripheral vascular disease and as an adjunctive treatment in certain respiratory conditions. Its therapeutic properties stem from its rich content of flavonoids and terpenoids, which confer antioxidant, anti-inflammatory, neuroprotective, and vasoregulatory effects. Research on GBE is extensive, with numerous randomized controlled trials and meta-analyses, though some studies note methodological limitations and heterogeneity in findings. Standardized extracts are preferred to ensure consistent concentrations of active compounds.

Benefits

Ginkgo biloba offers several evidence-based benefits. For cognitive function, meta-analyses show that GBE, especially when combined with conventional treatments like donepezil, significantly improves Mini-Mental State Examination (MMSE) scores in patients with dementia and Alzheimer's disease (RR=1.23, 95% CI 1.13–1.34, p<0.00001). Another meta-analysis reported improvements in MMSE and Activities of Daily Living (ADL) scores in MCI and AD patients after 24 weeks. In pulmonary function, GBE monotherapy and combined with prednisone significantly increased arterial oxygen partial pressure (PaO2) in idiopathic pulmonary fibrosis patients (p=0.033 and p<0.001 respectively). A meta-analysis of 18 RCTs found no significant effect of standardized GBE on bleeding risk parameters, suggesting a low risk of bleeding complications. Benefits typically become apparent after weeks to months of consistent use, with cognitive improvements often observed between 3 to 9 months.

How it works

Ginkgo biloba leaf extract (GBE) exerts its effects primarily through its active compounds: flavonoids and terpenoids. These compounds act as potent antioxidants, scavenging free radicals and reducing oxidative stress, which is crucial for neuroprotection. GBE also modulates various neurotransmitter systems, including cholinergic and glutamatergic pathways, contributing to its cognitive-enhancing properties. Furthermore, GBE improves microcirculation and blood flow by promoting vasodilation and inhibiting platelet aggregation, thereby enhancing oxygen and nutrient delivery to tissues, particularly in the brain and extremities. The bioavailability of GBE can vary, with standardized extracts ensuring a consistent concentration of active ingredients for optimal therapeutic effect.

Side effects

Ginkgo biloba is generally considered safe, with most adverse effects being mild. Common side effects, occurring in over 5% of users, include gastrointestinal discomfort, headaches, and dizziness. Less common side effects (1-5%) may involve allergic skin reactions. Rare side effects, occurring in less than 1% of users, include bleeding events, although a comprehensive meta-analysis indicated no significant increase in overall bleeding risk with typical doses. However, caution is advised due to potential interactions with anticoagulants and antiplatelet agents, which could theoretically increase bleeding risk. GBE is contraindicated in individuals with bleeding disorders or those scheduled for surgery without medical supervision. Data on its use in pregnancy and children are limited, so it is generally avoided or used only under medical guidance in these populations.

Dosage

The minimum effective dose for standardized Ginkgo biloba extract is typically 120 mg per day, formulated to contain 24% flavone glycosides and 6% terpene lactones. The optimal dosage range for most applications is between 120–240 mg per day, often divided into two doses. The maximum safe dose generally tolerated is up to 240 mg per day. Consistent daily dosing is recommended, as the benefits accumulate over several weeks to months. Standardized extracts are preferred to ensure consistent active compound concentrations. For enhanced absorption, GBE can be taken with meals, and fat-containing meals may further improve its bioavailability.

FAQs

Is Ginkgo biloba safe for long-term use?

Yes, Ginkgo biloba is generally considered safe for long-term use, with mild side effects and no major safety concerns reported in long-term randomized controlled trials.

Does Ginkgo biloba increase bleeding risk?

Evidence from a meta-analysis of 18 randomized controlled trials does not support an increased bleeding risk with typical doses of standardized Ginkgo biloba extract.

When can cognitive benefits be expected from Ginkgo biloba?

Cognitive benefits from Ginkgo biloba are typically observed after approximately 3 months of continuous and consistent use.

Can Ginkgo biloba be combined with Alzheimer’s medications?

Yes, studies have shown that combining Ginkgo biloba with medications like donepezil can lead to superior cognitive improvement in dementia patients.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1524505/full – This systematic review and meta-analysis found that Ginkgo biloba monotherapy and combined therapy significantly improved PaO2 and lung function parameters in idiopathic pulmonary fibrosis patients. The study noted moderate heterogeneity but assessed publication bias, indicating good methodological rigor for respiratory outcomes.
https://pubmed.ncbi.nlm.nih.gov/21923430/ – This meta-analysis of 18 randomized controlled trials involving 1985 adults concluded that standardized Ginkgo biloba extract had no significant effect on hemostasis or bleeding risk parameters. The study included diverse populations and utilized robust statistical analysis of high-quality RCTs.
https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2023.1124710/full – This meta-analysis of 6 RCTs involving 509 dementia patients demonstrated that Ginkgo biloba combined with donepezil significantly improved MMSE scores (RR=1.23, p<0.00001). The study, using a fixed-effects model, was of moderate to high quality despite some heterogeneity and sample size limitations.
https://www.jneurology.com/articles/commentary-ginkgo-biloba-for-mild-cognitive-impairment-and-alzheimer-s-disease-a-systematic-review-and-metaanalysis-of-randomized-.html – This systematic review and meta-analysis of 21 RCTs with 2608 patients with MCI/AD found that Ginkgo biloba improved MMSE and ADL scores over 24 weeks, with only mild adverse events. However, it highlighted moderate to poor methodological quality in some included trials and called for more rigorous future studies.